Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monte Rosa Therapeutics

4.09
-0.1300-3.08%
Post-market: 4.140.0500+1.22%19:41 EDT
Volume:423.62K
Turnover:1.75M
Market Cap:251.58M
PE:-4.16
High:4.59
Open:4.24
Low:4.05
Close:4.22
Loading ...
Jul 11, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jun 15, 2022

Major Issues Report

8-K - Current report
May 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2022

Major Issues Report

8-K - Current report
Mar 29, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Dec 15, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 08, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 28, 2021

Major Issues Report

8-K - Current report
Jun 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans